Reuters logo
BRIEF-Cara Therapeutics Inc reports Q3 loss per share $0.38
November 2, 2017 / 8:32 PM / 15 days ago

BRIEF-Cara Therapeutics Inc reports Q3 loss per share $0.38

Nov 2 (Reuters) - Cara Therapeutics Inc

* Cara Therapeutics Inc reports third quarter 2017 financial results

* Q3 loss per share $0.38

* Q3 earnings per share view $-0.34 -- Thomson Reuters I/B/E/S

* Cara Therapeutics Inc - expects existing cash and cash equivalents, among others to be sufficient to fund operating expenses, capex requirements into 2019​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below